Subject Index
Coagulation Factors and Inhibitors
Fibrinolysis, fibrinogen, fibrin
Haemorrhagic Disorders
Invited
Other
Platelets
Thrombotic Disorders and antithrombotic therapy
Vascular Biology
Coagulation Factors and Inhibitors
Animal and experimental models
AT, HCII, serine protease inhibitors
Contact phase
Factor IX and vitamin K-dependent factors
Factor XIII
Factor VIII, factor V
Methods
Other coagulation factors and inhibitions
Procoagulant phospholipids
Protein C, protein S, thrombomodulin
Structural biology and drug design
Thrombin, thrombin receptors
Tissue factor, TFPI, factor VII
A comparison of various evacuated blood collection tubes for monitoring warfarin therapy with Innovin
Munro R., Hardingham S., Dorward N. R., Morris K.
A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique
Lawrie A. S., Gray E., Leeming D., Davidson S. J., Purdy G., Iampietro R., Craig S., Rigsby P., Mackie I. J.
A new Global Plasma Fibrinolytic Assay for the rapid analysis of hyper-/hypo-Fibrinolysis: relationship with blood lipids and inflammatory markers
Zouaoui Boudjeltia K., Amiral J., Vissac A.-M., Deschepper N., Saccomando E., Vanhaeverbeek M., Cauchie P.
A novel method to accurately measure collagen/serotonin-induced platelet aggregation by whole blood impedance aggregometry in humans
Burggraaf J., Kemme M. J. B., Moerland M., Van Der Linden M., Cohen A. F.
A prospective multicentre study assessing the random error rates of routine coagulation tests
Malan E.
A rapid chromogenic method for determination of TAFI in plasma samples
Stürzebecher J., Prasa D., Ziegler H., Wilmer M., Wikström P.
An improved simpler method for using the ReFacto™ Laboratory Standard in monitoring patients receiving BDDrFVIII
Hillman-Wisman C., Llanto L., Hollon W., Lusher J. M.
Analytical validation of the automated measurement on STA-R of the ristocetin cofactor activity (VWF:RCo) of von Willebrand factor
Caron C., Trossaert M., Barat N., Nicham F., Fressinaud E., Goudemand J.
Comparative analysis of methods for detection of Activated Protein C resistance: an analysis of 755 consecutive patients
Matos M. F., Franco R. F., Silva C. R. S. S., Villela M. S. H., Figueiredo M. S.
Comparison of normal values for coagulation measurements in a variety of evacuated containers
Munro R., Hardingham S., Dorward N. R., Morris K.
Detection of procoagulants with a more reliable nonactivated clotting test
Exner T., Joseph J., Low J., Connor D., Ma D.
Development of a biosensor system for self-testing the intensity of anti-coagulation by anti-coagulated patients in capillary whole blood
Thuerlemann C., Frenkel E. J., Dinger R., Haeberli A.
Equivalence of venous and capillary INR values determined with the new CoaguChek® PT.S-test on the CoaguChek® S system
Plesch W., Klimpel P., Miller E., Fuller J., Newhart A., Jacobson A., Gutnik L.
Factor V Leiden mutation (FV:Q506): A new functional screening assay with 100% specificity and sensitivity
Wilmer M., Stocker C., Piccapietra B., Böck M., Bombeli T.
Frozen or lyophilized normal plasmas pose a strong bias for reporting PT values
Henckel T., Becker U.
In terms of clinical impact, thromboplastins with an ISI close to 1 yield better results than thromboplastins with an ISI close to 2, in an external quality control campaign
Simonnet V., Léger P., Nguyen F., Boneu B., Cambus J. P.
Increased factor V level and preanalytical coagulation
Eschwege V., Trillard M., Robert A.
Influence of time interval after sampling on variability of thrombelastography (TEG) results
Kretschmer V., Daraktchiev A.
Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
Paniccia R., Pretelli P., Stefano P. L., Costanzo M., Bandinelli B., Conti A. A., Attanasio M., Pieralli M., Abbate R., Gensini G. F., Prisco D., Paniccia R., Pretelli P., Stefano P. L., Costanzo M., Bandinelli B., Conti A. A., Attanasio M., Pieralli M., Abbate R., Gensini G. F., Prisco D.
Multicenter evaluation of a new polymer tube (Vacuette Sandwich) for coagulation testing. Effect on routine coagulation tests and on plasma levels of markers of coagulation activation
Arnoux D., Borg J. Y., Delahousse B., Robert A., Toulon P. A.
Normal platelet-poor plasma correction studies in the laboratory diagnosis of lupus anticoagulant
Thom J. Y., Ivey L., Eikelboom J.
Optimal concentrations of inhibitors, zymogens and procofactors of coagulation
Tyurin K.
Performance evaluation of the new CoaguChek® PT.S-test on the CoaguChek® S system
Plesch W., Klimpel P., Miller E., Fuller J., Newhart A., Jacobson A., Gutnik L., Dikkeschei L. D.
Performance of a new PT Calibrator
Merz M., Henckel T., Engelhardt W.
Platelet mediated thrombin generation depends on F VIII and Factor IX in a complex way: evidences for the Cell-based model of hemostasis
Siegemund A., Siegemund T., Petros S., Scholz U., Engelmann L.
Population pharmacokinetics of the ReFacto coagulation factor VIII in clinical hemophilia patients with HIV
Lukas J. C., Anastasopoulou I., Katsarou O., Xiachopoulou P., Martin Suarez A., Zografidis T., Kotsi P., Karafoulidou A.
Reference ranges for hemostatic parameters in children
Monagle P., Ignjatovic V., Barnes C., Newall F., Campbell J., Savoia H., Furmedge J.
Reproducibility of anticoagulation therapy control tested on fresh and frozen plasma
Karas G. K., Sturm D., Banovic M.
ROTEG thromboelastography: sample stability and results in warfarinized and heparinized patients
Woolley A. M., Hunter A., Hampton K. K., Makris M., Kitchen S.
Sample management and quality control in roTEG thrombelastography
Christiansen K., Sorensen B., Ingerslev J.
Standardization of activated protein C resistance testing: effect of residual platelets in frozen plasmas assessed with commercial and home made methods
Chantarangkul V., Tripodi A., Valsecchi C., Battaglioli T., Mannucci P. M.
The calibrated Thrombogram: exact monitoring of thrombin generation in clotting platelet rich- and platelet poor plasma
Giesen P., Al Dieri R., Wagenvoord R., Nijhuis S., Béguin S., Hemker H. C.
The choice of tubes for blood collection – a plastic tube is not enough
Ramström S., Lindahl T. L.
The influence of the prothrombin mutation 20210 GA and the level of prothrombin on the thrombin generation
Siegemund A., Siegemund T., Petros S., Scholz U., Engelmann L.
The long-term analytical performance of assay of anti-thrombin, protein C and protein
Meijer P., Haverkate F., De Maat M. P. M., Kluft C.
The Nijmegen low-titer factor VIII inhibitor assay: a highly sensitive assay for the detection of low-titer factor VIII inhibitors
Verbruggen B., Van Heerde W. L., Lourenssen G., Mensink E., Novakova I. R. O.
The suitability of various evacuated blood collection tubes for monitoring heparin
Munro R., Hardingham S., Dorward N., Morris K.
The use of corn trypsin inhibitor to reduce the effect of sample contact activation in assays utilizing low tissue factor
Luddington R., Langdown J., Baglin T.
Thrombin generation assessed as endogenous thrombin potential (ETP) in patients with hyper- or hypo-coagulability. Effects of phospholipids, tissue factor and residual platelets on the measurement performed in platelet-poor and platelet-rich plasma
Chantarangkul V., Clerici M., Bressi C., Giesen P. L. A., Tripodi A.
Thrombinography can differentiate bleeding from nonbleeding patients with prolonged APTT
Regnault V., Briquel M. E., Nguyen P., Laurian Y., Béguin S., Hemker H. C., Lecompte T.
Use of a decision-making system based on the Fuzzy sets theory applied to the routine of results' release in the haemostasis laboratory: how to do it better and quicker
Franco R. F., Matos M. F., Garcia P. F., Fontes F. S., Gomide F., Molina J. F., Figueiredo M. S., Villela M. S. H., Vieira J. G. H., Ghiringhello M. T.
VWF:RCo assay implementation on automated coagulometer
Redaelli R., Borroni L., Mostarda G., Corno A. R., Morra E., Baudo F.